<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37681895</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Medium-Chain Fatty Acids Rescue Motor Function and Neuromuscular Junction Degeneration in a <i>Drosophila</i> Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12172163</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterised by progressive degeneration of the motor neurones. An expanded <i>GGGGCC (G4C2)</i> hexanucleotide repeat in <i>C9orf72</i> is the most common genetic cause of ALS and frontotemporal dementia (FTD); therefore, the resulting disease is known as C9ALS/FTD. Here, we employ a <i>Drosophila melanogaster</i> model of C9ALS/FTD (C9 model) to investigate a role for specific medium-chain fatty acids (MCFAs) in reversing pathogenic outcomes. <i>Drosophila</i> larvae overexpressing the ALS-associated dipeptide repeats (DPRs) in the nervous system exhibit reduced motor function and neuromuscular junction (NMJ) defects. We show that two MCFAs, nonanoic acid (NA) and 4-methyloctanoic acid (4-MOA), can ameliorate impaired motor function in C9 larvae and improve NMJ degeneration, although their mechanisms of action are not identical. NA modified postsynaptic glutamate receptor density, whereas 4-MOA restored defects in the presynaptic vesicular release. We also demonstrate the effects of NA and 4-MOA on metabolism in C9 larvae and implicate various metabolic pathways as dysregulated in our ALS model. Our findings pave the way to identifying novel therapeutic targets and potential treatments for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>Ella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinert</LastName><ForeName>Joern R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0003-1640-0845</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine &amp; Health Sciences, Queen's Medical Centre, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Aelfwin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine &amp; Health Sciences, Queen's Medical Centre, Nottingham NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahota</LastName><ForeName>Virender</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Robin S B</ForeName><Initials>RSB</Initials><Identifier Source="ORCID">0000-0002-9826-6020</Identifier><AffiliationInfo><Affiliation>Centre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snowden</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augustin</LastName><ForeName>Hrvoje</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007814" MajorTopicYN="N">Larva</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">4-MOA</Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Drosophila</Keyword><Keyword MajorTopicYN="N">MCFA</Keyword><Keyword MajorTopicYN="N">NA</Keyword><Keyword MajorTopicYN="N">NMJ</Keyword><Keyword MajorTopicYN="N">glutamate</Keyword><Keyword MajorTopicYN="N">motor function</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>8</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37681895</ArticleId><ArticleId IdType="pmc">PMC10486503</ArticleId><ArticleId IdType="doi">10.3390/cells12172163</ArticleId><ArticleId IdType="pii">cells12172163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barbieri E. Epidemiology of ALS: Incidence, Prevalence, and Suspected Clusters. TargetALS.org 2022.  [(accessed on 25 July 2023)].  Available online:  https://www.targetals.org/2022/11/22/epidemiology-of-als-incidence-prevalence-and-clusters/</Citation></Reference><Reference><Citation>Hulisz D. Amyotrophic lateral sclerosis: Disease state overview. Am. J. Manag. Care. 2018;24:S320&#x2013;S326.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Bianchi E., Pupillo E., Lunetta C., Tremolizzo L., Logroscino G., Chi&#xf2; A., Preux P.M., Beghi E. Non-self-sufficiency as a primary outcome measure in ALS trials. Amyotroph. Lateral Scler. Front. Degener. 2015;17:77&#x2013;84. doi: 10.3109/21678421.2015.1074704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1074704</ArticleId><ArticleId IdType="pubmed">26470831</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo M., Lunetta C., Zuccarino R., Vita G.L., Sframeli M., Lizio A., La Foresta S., Faraone C., Sansone V.A., Vita G., et al. The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis. Sci. Rep. 2020;10:15580. doi: 10.1038/s41598-020-72578-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72578-3</ArticleId><ArticleId IdType="pmc">PMC7511965</ArticleId><ArticleId IdType="pubmed">32968168</ArticleId></ArticleIdList></Reference><Reference><Citation>Inam S., Vucic S., Brodaty N.E., Zoing M.C., Kiernan M.C. The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. 2010;11:558&#x2013;561. doi: 10.3109/17482961003792958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003792958</ArticleId><ArticleId IdType="pubmed">20515425</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras I., Yuruker S., Aytan N., Hossain L., Choi J.K., Jenkins B.G., Kowall N.W., Dedeoglu A. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res. 2010;1313:192&#x2013;201. doi: 10.1016/j.brainres.2009.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.11.051</ArticleId><ArticleId IdType="pmc">PMC2892864</ArticleId><ArticleId IdType="pubmed">19968977</ArticleId></ArticleIdList></Reference><Reference><Citation>Drory V.E., Goltsman E., Reznik J.G., Mosek A., Korczyn A.D. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2001;191:133&#x2013;137. doi: 10.1016/S0022-510X(01)00610-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00610-4</ArticleId><ArticleId IdType="pubmed">11677004</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka H., Murata K., Sugisawa T., Shibukawa M., Ebina J., Sawada M., Hanashiro S., Nagasawa J., Yanagihashi M., Hirayama T., et al. Effects of Long-term Hybrid Assistive Limb Use on Gait in Patients with Amyotrophic Lateral Sclerosis. Intern. Med. 2022;61:1479&#x2013;1484. doi: 10.2169/internalmedicine.8030-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.8030-21</ArticleId><ArticleId IdType="pmc">PMC9177366</ArticleId><ArticleId IdType="pubmed">35569927</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty M.J. Amyotrophic lateral sclerosis as a synaptopathy. Neural Regen. Res. 2019;14:189&#x2013;192. doi: 10.4103/1673-5374.244782.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.244782</ArticleId><ArticleId IdType="pmc">PMC6301167</ArticleId><ArticleId IdType="pubmed">30530995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Arias N. Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion. Front. Cell. Neurosci. 2021;15:660693. doi: 10.3389/fncel.2021.660693.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.660693</ArticleId><ArticleId IdType="pmc">PMC8203826</ArticleId><ArticleId IdType="pubmed">34140881</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.L., Garc&#xed;a-Ayll&#xf3;n M.S., Ciura S., S&#xe1;ez-Valero J., Kabashi E. Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front. Mol. Neurosci. 2016;9:160. doi: 10.3389/fnmol.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00160</ArticleId><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.A., Southam K.A., Blizzard C.A., King A.E., Dickson T.C. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Chem. Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Bauch&#xe9; S., Gonzalez de Aguilar J.L., Brochier G., Mandjee N., Tanguy M.L., Hussain G., Behin A., Khiami F., Sariali E., et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann. Clin. Transl. Neurol. 2015;2:362&#x2013;372. doi: 10.1002/acn3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S.R., Shah S.B., Lovering R.M. The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease. Int. J. Mol. Sci. 2021;22:8058. doi: 10.3390/ijms22158058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158058</ArticleId><ArticleId IdType="pmc">PMC8347593</ArticleId><ArticleId IdType="pubmed">34360831</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin K., Khabbush A., Williams S., Eaton S., Orford M., Cross J.H., Heales S.J.R., Walker M.C., Williams R.S.B. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 2018;17:84&#x2013;93. doi: 10.1016/S1474-4422(17)30408-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30408-8</ArticleId><ArticleId IdType="pubmed">29263011</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatikopoulou M.G., Goulis D.G., Gkiouras K., Theodoridis X., Gkouskou K.K., Evangeliou A., Dardiotis E., Bogdanos D.P. To Keto or Not to Keto? A Systematic Review of Randomized Controlled Trials Assessing the Effects of Ketogenic Therapy on Alzheimer Disease. Adv. Nutr. 2020;11:1583&#x2013;1602. doi: 10.1093/advances/nmaa073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmaa073</ArticleId><ArticleId IdType="pmc">PMC7666893</ArticleId><ArticleId IdType="pubmed">32597927</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatikopoulou M.G., Tousinas G., Balodimou C., Anastasilakis D.A., Gkiouras K., Dardiotis E., Evangeliou A.E., Bogdanos D.P., Goulis D.G. Ketogenic therapy for Parkinson&#x2019;s disease: A systematic review and synthesis without meta-analysis of animal and human trials. Maturitas. 2022;163:46&#x2013;61. doi: 10.1016/j.maturitas.2022.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2022.06.001</ArticleId><ArticleId IdType="pubmed">35714419</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedlack R., Barkhaus P.E., Barnes B., Beauchamp M., Bertorini T., Bromberg M.B., Carter G.T., Chaudry V., Cudkowicz M., Jackson C., et al. ALSUntangled #63: Ketogenic diets. Amyotroph. Lateral Scler. Front. Degener. 2023;24:159&#x2013;163. doi: 10.1080/21678421.2021.1990346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1990346</ArticleId><ArticleId IdType="pubmed">34645313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Varghese M., Vempati P., Dzhun A., Cheng A., Wang J., Lange D., Bilski A., Faravelli I., Pasinetti G.M. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE. 2012;7:e49191. doi: 10.1371/journal.pone.0049191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049191</ArticleId><ArticleId IdType="pmc">PMC3492315</ArticleId><ArticleId IdType="pubmed">23145119</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P., Orabi B., Deranieh R.M., Dham M., Hoeller O., Shimshoni J.A., Yagen B., Bialer M., Greenberg M.L., Walker M.C., et al. The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium. Dis. Models Mech. 2012;5:115&#x2013;124. doi: 10.1242/dmm.008029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.008029</ArticleId><ArticleId IdType="pmc">PMC3255550</ArticleId><ArticleId IdType="pubmed">21876211</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P., Terbach N., Plant N., Chen P.E., Walker M.C., Williams R.S. Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology. 2013;69:105&#x2013;114. doi: 10.1016/j.neuropharm.2012.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.11.004</ArticleId><ArticleId IdType="pmc">PMC3625124</ArticleId><ArticleId IdType="pubmed">23177536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P., Augustin K., Boddum K., Williams S., Sun M., Terschak J.A., Hardege J.D., Chen P.E., Walker M.C., Williams R.S. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain. 2016;139:431&#x2013;443. doi: 10.1093/brain/awv325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv325</ArticleId><ArticleId IdType="pmc">PMC4805082</ArticleId><ArticleId IdType="pubmed">26608744</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh M.E., Fournier C., Li Y., Polak M., Shaw L., Landers J.E., Hu W., Gearing M., Glass J.D. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology. 2016;87:1024&#x2013;1030. doi: 10.1212/WNL.0000000000003067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003067</ArticleId><ArticleId IdType="pmc">PMC5027809</ArticleId><ArticleId IdType="pubmed">27488601</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ende E.L., Jackson J.L., White A., Seelaar H., van Blitterswijk M., Van Swieten J.C. Unravelling the clinical spectrum and the role of repeat length in. J. Neurol. Neurosurg. Psychiatry. 2021;92:502&#x2013;509. doi: 10.1136/jnnp-2020-325377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325377</ArticleId><ArticleId IdType="pmc">PMC8053328</ArticleId><ArticleId IdType="pubmed">33452054</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Taylor J.P. The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD. Front. Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O.C., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell. 2016;167:774&#x2013;788.e717. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S., Han Y., Das A., Dickman D. Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration. Hum. Mol. Genet. 2017;26:4153&#x2013;4167. doi: 10.1093/hmg/ddx304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx304</ArticleId><ArticleId IdType="pmc">PMC5886083</ArticleId><ArticleId IdType="pubmed">28973139</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401&#x2013;415. doi: 10.1242/dev.118.2.401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.118.2.401</ArticleId><ArticleId IdType="pubmed">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin H., McGourty K., Steinert J.R., Cochem&#xe9; H.M., Adcott J., Cabecinha M., Vincent A., Halff E.F., Kittler J.T., Boucrot E., et al. Myostatin-like proteins regulate synaptic function and neuronal morphology. Development. 2017;144:2445&#x2013;2455. doi: 10.1242/dev.152975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.152975</ArticleId><ArticleId IdType="pmc">PMC5536874</ArticleId><ArticleId IdType="pubmed">28533206</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S.W., Bourgognon J.M., Spiers J.G., Breda C., Campesan S., Butcher A., Mallucci G.R., Dinsdale D., Morone N., Mistry R., et al. Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability. PLoS Biol. 2018;16:e2003611. doi: 10.1371/journal.pbio.2003611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2003611</ArticleId><ArticleId IdType="pmc">PMC5890968</ArticleId><ArticleId IdType="pubmed">29630591</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone A., Cujic O., Rowlett A., Aderhold S., Savage E., Graham B., Steinert J.R. Triose-phosphate isomerase deficiency is associated with a dysregulation of synaptic vesicle recycling in Drosophila melanogaster. Front. Synaptic Neurosci. 2023;15:1124061. doi: 10.3389/fnsyn.2023.1124061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsyn.2023.1124061</ArticleId><ArticleId IdType="pmc">PMC10011161</ArticleId><ArticleId IdType="pubmed">36926383</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart B.A., Atwood H.L., Renger J.J., Wang J., Wu C.F. Improved stability of Drosophila larval neuromuscular preparations in haemolymph-like physiological solutions. J. Comp. Physiol. A. 1994;175:179&#x2013;191. doi: 10.1007/BF00215114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00215114</ArticleId><ArticleId IdType="pubmed">8071894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebshiana A.A., Snowden S.G., Thambisetty M., Parsons R., Hye A., Legido-Quigley C. Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction. PLoS ONE. 2015;10:e0122883. doi: 10.1371/journal.pone.0122883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122883</ArticleId><ArticleId IdType="pmc">PMC4390242</ArticleId><ArticleId IdType="pubmed">25853858</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes H.J.R., Kent J.P., Bruntraeger M., Bassett A.R., Koulman A., Metzakopian E., Snowden S.G. Mitochondrial and Endoplasmic Reticulum Stress Trigger Triglyceride Accumulation in Models of Parkinson&#x2019;s Disease Independent of Mutations in MAPT. Metabolites. 2023;13:112. doi: 10.3390/metabo13010112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13010112</ArticleId><ArticleId IdType="pmc">PMC9861589</ArticleId><ArticleId IdType="pubmed">36677037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers M.C., Maclean B., Burke R., Amodei D., Ruderman D.L., Neumann S., Gatto L., Fischer B., Pratt B., Egertson J., et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 2012;30:918&#x2013;920. doi: 10.1038/nbt.2377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2377</ArticleId><ArticleId IdType="pmc">PMC3471674</ArticleId><ArticleId IdType="pubmed">23051804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl C., Tautenhahn R., B&#xf6;ttcher C., Larson T.R., Neumann S. CAMERA: An integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal. Chem. 2012;84:283&#x2013;289. doi: 10.1021/ac202450g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac202450g</ArticleId><ArticleId IdType="pmc">PMC3658281</ArticleId><ArticleId IdType="pubmed">22111785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyal S. Genomic mapping and expression patterns of C380, OK6 and D42 enhancer trap lines in the larval nervous system of Drosophila. Gene Expr. Patterns. 2009;9:371&#x2013;380. doi: 10.1016/j.gep.2009.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gep.2009.01.002</ArticleId><ArticleId IdType="pubmed">19602393</ArticleId></ArticleIdList></Reference><Reference><Citation>Melom J.E., Akbergenova Y., Gavornik J.P., Littleton J.T. Spontaneous and evoked release are independently regulated at individual active zones. J. Neurosci. 2013;33:17253&#x2013;17263. doi: 10.1523/JNEUROSCI.3334-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3334-13.2013</ArticleId><ArticleId IdType="pmc">PMC3812501</ArticleId><ArticleId IdType="pubmed">24174659</ArticleId></ArticleIdList></Reference><Reference><Citation>Peron S., Zordan M.A., Magnabosco A., Reggiani C., Megighian A. From action potential to contraction: Neural control and excitation-contraction coupling in larval muscles of Drosophila. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2009;154:173&#x2013;183. doi: 10.1016/j.cbpa.2009.04.626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2009.04.626</ArticleId><ArticleId IdType="pubmed">19427393</ArticleId></ArticleIdList></Reference><Reference><Citation>DiAntonio A., Petersen S.A., Heckmann M., Goodman C.S. Glutamate receptor expression regulates quantal size and quantal content at the Drosophila neuromuscular junction. J. Neurosci. 1999;19:3023&#x2013;3032. doi: 10.1523/JNEUROSCI.19-08-03023.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-08-03023.1999</ArticleId><ArticleId IdType="pmc">PMC6782296</ArticleId><ArticleId IdType="pubmed">10191319</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins C.A., DiAntonio A. Synaptic development: Insights from Drosophila. Curr. Opin. Neurobiol. 2006;17:35&#x2013;42. doi: 10.1016/j.conb.2007.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2007.01.001</ArticleId><ArticleId IdType="pubmed">17229568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Ca&#xf1;ada C., Budnik V. Introduction on the use of the Drosophila embryonic/larval neuromuscular junction as a model system to study synapse development and function, and a brief summary of pathfinding and target recognition. Int. Rev. Neurobiol. 2006;75:1&#x2013;31. doi: 10.1016/S0074-7742(06)75001-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0074-7742(06)75001-2</ArticleId><ArticleId IdType="pubmed">17137921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigrist S.J., Thiel P.R., Reiff D.F., Schuster C.M. The postsynaptic glutamate receptor subunit DGluR-IIA mediates long-term plasticity in Drosophila. J. Neurosci. 2002;22:7362&#x2013;7372. doi: 10.1523/JNEUROSCI.22-17-07362.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-17-07362.2002</ArticleId><ArticleId IdType="pmc">PMC6757995</ArticleId><ArticleId IdType="pubmed">12196557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P., Zuckermann A.M., Williams S., Close A.J., Cano-Jaimez M., McEvoy J.P., Spencer J., Walker M.C., Williams R.S. Seizure control by derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency. J. Pharmacol. Exp. Ther. 2015;352:43&#x2013;52. doi: 10.1124/jpet.114.218768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.114.218768</ArticleId><ArticleId IdType="pubmed">25326131</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang Y.W., Jung J.Y., Lee I.K., Kang S.Y., Yun B.S. Nonanoic Acid, an Antifungal Compound from Hibiscus syriacus Ggoma. Mycobiology. 2012;40:145&#x2013;146. doi: 10.5941/MYCO.2012.40.2.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.5941/MYCO.2012.40.2.145</ArticleId><ArticleId IdType="pmc">PMC3408307</ArticleId><ArticleId IdType="pubmed">22870060</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Huang N., Xiong J., Wei H., Jiang S., Peng J. Caprylic acid and nonanoic acid upregulate endogenous host defense peptides to enhance intestinal epithelial immunological barrier function via histone deacetylase inhibition. Int. Immunopharmacol. 2018;65:303&#x2013;311. doi: 10.1016/j.intimp.2018.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.10.022</ArticleId><ArticleId IdType="pubmed">30342347</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson W., Heldreth B., Bergfeld W.F., Belsito D.V., Klaassen C.D., Hill R., Liebler D., Marks J.G., Shank R.C., Slaga T.J., et al. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of pelargonic acid (nonanoic acid) and nonanoate esters. Int. J. Toxicol. 2011;30:228S&#x2013;269S. doi: 10.1177/1091581811428980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1091581811428980</ArticleId><ArticleId IdType="pubmed">22247237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamata Y., Shiraga H., Tai A., Kawamoto Y., Gohda E. Induction of neurite outgrowth in PC12 cells by the medium-chain fatty acid octanoic acid. Neuroscience. 2007;146:1073&#x2013;1081. doi: 10.1016/j.neuroscience.2007.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2007.03.001</ArticleId><ArticleId IdType="pubmed">17434686</ArticleId></ArticleIdList></Reference><Reference><Citation>Armada-Moreira A., Gomes J.I., Pina C.C., Savchak O.K., Gon&#xe7;alves-Ribeiro J., Rei N., Pinto S., Morais T.P., Martins R.S., Ribeiro F.F., et al. Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases. Front. Cell. Neurosci. 2020;14:90. doi: 10.3389/fncel.2020.00090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00090</ArticleId><ArticleId IdType="pmc">PMC7194075</ArticleId><ArticleId IdType="pubmed">32390802</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V., Richard P., Hoque M., Li C., Gu Z., Fissore-O&#x2019;Leary M., Tian B., Prives C., Manley J.L. The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling. Mol. Cell. Biol. 2018;38:e00155-18. doi: 10.1128/MCB.00155-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>Pflanz N.C., Daszkowski A.W., James K.A., Mihic S.J. Ketone body modulation of ligand-gated ion channels. Neuropharmacology. 2019;148:21&#x2013;30. doi: 10.1016/j.neuropharm.2018.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.12.013</ArticleId><ArticleId IdType="pubmed">30562540</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanback A.E. The Effects of a Ketone Body on Synaptic Transmission. Theses Diss.-Biol. 2019:57. doi: 10.13023/etd.2019.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.13023/etd.2019.183</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton B.K. Urea cycle disorders. Clin. Liver Dis. 2000;4:815&#x2013;830. doi: 10.1016/S1089-3261(05)70143-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1089-3261(05)70143-4</ArticleId><ArticleId IdType="pubmed">11232359</ArticleId></ArticleIdList></Reference><Reference><Citation>Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 2002;67:259&#x2013;279. doi: 10.1016/S0301-0082(02)00019-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(02)00019-9</ArticleId><ArticleId IdType="pubmed">12207972</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova P.R., Kerbert A.J.C., Habtesion A., Hall A., Abramov A.Y., Jalan R. Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death. JHEP Rep. 2022;4:100510. doi: 10.1016/j.jhepr.2022.100510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhepr.2022.100510</ArticleId><ArticleId IdType="pmc">PMC9278080</ArticleId><ArticleId IdType="pubmed">35845295</ArticleId></ArticleIdList></Reference><Reference><Citation>Parekh B. A(a)LS: Ammonia-induced amyotrophic lateral sclerosis. F1000Research. 2015;4:119. doi: 10.12688/f1000research.6364.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.6364.1</ArticleId><ArticleId IdType="pmc">PMC5063041</ArticleId><ArticleId IdType="pubmed">27785351</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten B.M., Kurlander H.M., Evans B. Free amino acid concentrations in spinal tissue from patients dying of motor neuron disease. Acta Neurol. Scand. 1982;66:594&#x2013;599. doi: 10.1111/j.1600-0404.1982.tb03148.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1982.tb03148.x</ArticleId><ArticleId IdType="pubmed">7148401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bame M., Grier R.E., Needleman R., Brusilow W.S. Amino acids as biomarkers in the SOD1(G93A) mouse model of ALS. Biochim. Biophys. Acta. 2014;1842:79&#x2013;87. doi: 10.1016/j.bbadis.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.10.004</ArticleId><ArticleId IdType="pubmed">24129262</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Quintana L., Llarena M., Reyes-Su&#xe1;rez D., Ald&#xe1;miz-Echevarria L. Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: Patient perspectives. Patient Prefer. Adherence. 2017;11:1489&#x2013;1496. doi: 10.2147/PPA.S136754.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S136754</ArticleId><ArticleId IdType="pmc">PMC5593420</ArticleId><ArticleId IdType="pubmed">28919721</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Hendrix S., Berry J.D., Elliott M.A., Maiser S., Karam C., Caress J.B., Owegi M.A., Quick A., et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2020;383:919&#x2013;930. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H., Smith K., Camelo S.I., Carreras I., Lee J., Iglesias A.H., Dangond F., Cormier K.A., Cudkowicz M.E., Brown R.H., et al. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J. Neurochem. 2005;93:1087&#x2013;1098. doi: 10.1111/j.1471-4159.2005.03077.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03077.x</ArticleId><ArticleId IdType="pubmed">15934930</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur B., Bhat A., Chakraborty R., Adlakha K., Sengupta S., Roy S., Chakraborty K. Proteomic profile of 4-PBA treated human neuronal cells during ER stress. Mol. Omics. 2018;14:53&#x2013;63. doi: 10.1039/C7MO00114B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7MO00114B</ArticleId><ArticleId IdType="pubmed">29570205</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfrey E.W., Schwarte R.C. The role of nitric oxide signaling in the formation of the neuromuscular junction. J. Neurocytol. 2003;32:591&#x2013;602. doi: 10.1023/B:NEUR.0000020612.87729.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:NEUR.0000020612.87729.98</ArticleId><ArticleId IdType="pubmed">15034255</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott A.B., Bossy-Wetzel E. Nitric oxide in health and disease of the nervous system. Antioxid. Redox Signal. 2009;11:541&#x2013;554. doi: 10.1089/ars.2008.2234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2008.2234</ArticleId><ArticleId IdType="pmc">PMC2933573</ArticleId><ArticleId IdType="pubmed">18715148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley S.A., Steinert J.R. Nitric Oxide-Mediated Posttranslational Modifications: Impacts at the Synapse. Oxid. Med. Cell. Longev. 2016;2016:5681036. doi: 10.1155/2016/5681036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5681036</ArticleId><ArticleId IdType="pmc">PMC4655263</ArticleId><ArticleId IdType="pubmed">26635909</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaught K.S., Brown G.C. Nitric oxide causes glutamate release from brain synaptosomes. J. Neurochem. 1998;70:1541&#x2013;1546. doi: 10.1046/j.1471-4159.1998.70041541.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.70041541.x</ArticleId><ArticleId IdType="pubmed">9523571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 2001;21:6480&#x2013;6491. doi: 10.1523/JNEUROSCI.21-17-06480.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-17-06480.2001</ArticleId><ArticleId IdType="pmc">PMC6763071</ArticleId><ArticleId IdType="pubmed">11517237</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon C.H., Tsui K.C., Chau S.C., Chong P.S., Lui S.W.Y., Aquili L., Wong K.H., Lim L.W. Functional Roles of Neuronal Nitric Oxide Synthase in Neurodegenerative Diseases and Mood Disorders. Curr. Alzheimer Res. 2021;18:831&#x2013;840. doi: 10.2174/1567205018666211022164025.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205018666211022164025</ArticleId><ArticleId IdType="pubmed">34719364</ArticleId></ArticleIdList></Reference><Reference><Citation>Drechsel D.A., Est&#xe9;vez A.G., Barbeito L., Beckman J.S. Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotox. Res. 2012;22:251&#x2013;264. doi: 10.1007/s12640-012-9322-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-012-9322-y</ArticleId><ArticleId IdType="pmc">PMC4145402</ArticleId><ArticleId IdType="pubmed">22488161</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 1997;42:644&#x2013;654. doi: 10.1002/ana.410420416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420416</ArticleId><ArticleId IdType="pubmed">9382477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante R.J., Shinobu L.A., Schulz J.B., Matthews R.T., Thomas C.E., Kowall N.W., Gurney M.E., Beal M.F. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann. Neurol. 1997;42:326&#x2013;334. doi: 10.1002/ana.410420309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420309</ArticleId><ArticleId IdType="pubmed">9307254</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paola M., Sestito S.E., Mariani A., Memo C., Fanelli R., Freschi M., Bendotti C., Calabrese V., Peri F. Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model. Pharmacol. Res. 2016;103:180&#x2013;187. doi: 10.1016/j.phrs.2015.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2015.11.020</ArticleId><ArticleId IdType="pubmed">26640075</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli G.P., Friedrich V.L., Holstein G.R. L-citrulline immunostaining identifies nitric oxide production sites within neurons. Neuroscience. 2002;114:111&#x2013;122. doi: 10.1016/S0306-4522(02)00238-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(02)00238-5</ArticleId><ArticleId IdType="pubmed">12207959</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A., Gautam S., Hyeon S.J., Ryu H., Kang Y.S. L-Citrulline Level and Transporter Activity Are Altered in Experimental Models of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2021;58:647&#x2013;657. doi: 10.1007/s12035-020-02143-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02143-6</ArticleId><ArticleId IdType="pubmed">33000451</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>